346 related articles for article (PubMed ID: 14528055)
21. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
[TBL] [Abstract][Full Text] [Related]
22. Brain proteasomal function in sporadic Parkinson's disease and related disorders.
Furukawa Y; Vigouroux S; Wong H; Guttman M; Rajput AH; Ang L; Briand M; Kish SJ; Briand Y
Ann Neurol; 2002 Jun; 51(6):779-82. PubMed ID: 12112087
[TBL] [Abstract][Full Text] [Related]
23. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
24. The ubiquitin-proteasome system in neurodegeneration.
McKinnon C; Tabrizi SJ
Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
[TBL] [Abstract][Full Text] [Related]
25. New genetic insights into Parkinson's disease.
Feany MB
N Engl J Med; 2004 Nov; 351(19):1937-40. PubMed ID: 15525720
[No Abstract] [Full Text] [Related]
26. Proteasome inhibition and aggregation in Parkinson's disease: a comparative study in untransfected and transfected cells.
Biasini E; Fioriti L; Ceglia I; Invernizzi R; Bertoli A; Chiesa R; Forloni G
J Neurochem; 2004 Feb; 88(3):545-53. PubMed ID: 14720204
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.
Ciechanover A; Brundin P
Neuron; 2003 Oct; 40(2):427-46. PubMed ID: 14556719
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Role of Ubiquitin-Proteasome System in Parkinson's Disease.
Behl T; Kumar S; Althafar ZM; Sehgal A; Singh S; Sharma N; Badavath VN; Yadav S; Bhatia S; Al-Harrasi A; Almoshari Y; Almikhlafi MA; Bungau S
Mol Neurobiol; 2022 Jul; 59(7):4257-4273. PubMed ID: 35505049
[TBL] [Abstract][Full Text] [Related]
29. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
Tydlacka S; Wang CE; Wang X; Li S; Li XJ
J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220
[TBL] [Abstract][Full Text] [Related]
30. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
Forloni G; Terreni L; Bertani I; Fogliarino S; Invernizzi R; Assini A; Ribizzi G; Negro A; Calabrese E; Volonté MA; Mariani C; Franceschi M; Tabaton M; Bertoli A
Neurobiol Aging; 2002; 23(5):957-76. PubMed ID: 12392798
[TBL] [Abstract][Full Text] [Related]
31. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
32. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
33. Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
Lindsten K; de Vrij FM; Verhoef LG; Fischer DF; van Leeuwen FW; Hol EM; Masucci MG; Dantuma NP
J Cell Biol; 2002 Apr; 157(3):417-27. PubMed ID: 11980917
[TBL] [Abstract][Full Text] [Related]
34. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
35. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
Hol EM; van Leeuwen FW; Fischer DF
Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
[TBL] [Abstract][Full Text] [Related]
36. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
Coleman MP; Ribchester RR
Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
[TBL] [Abstract][Full Text] [Related]
37. The ubiquitin-proteasome system and neurodegenerative disorders.
Layfield R; Lowe J; Bedford L
Essays Biochem; 2005; 41():157-71. PubMed ID: 16250904
[TBL] [Abstract][Full Text] [Related]
38. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
McLean PJ; Kawamata H; Hyman BT
Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.
Donaldson KM; Li W; Ching KA; Batalov S; Tsai CC; Joazeiro CA
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8892-7. PubMed ID: 12857950
[TBL] [Abstract][Full Text] [Related]
40. From neurodegeneration to neurohomeostasis: the role of ubiquitin.
Mayer RJ
Drug News Perspect; 2003 Mar; 16(2):103-8. PubMed ID: 12792671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
